Jiangsu JLand Biotech Co.
Latest round
- Series C
Last raised
- May 2025
Total raised
- $14M
Investors
- 5
About Jiangsu JLand Biotech Co.
, Ltd. operates as a biomimetic technology developer that provides non-animal-derived collagen. The company has branches in Hangzhou, Shaoxing, Shanghai and Europe. It cooperated with the Nanjing University of Science and Technology to establish the Jiangsu Recombinant Collagen Engineering Research Center and also cooperates with Fudan University, Huashida University and China Pharmaceutical University. In 2016, the company's recombinant human collagen was industrialized. In March 2023, it was awarded as "InnoCosme Awards Meiyao Award". JLand mainly provides recombinant human collagen and downstream products based on bioengineering technology such as genetic recombination, microbial fermentation, protein isolation and purification. Its brands include Kemeishi and Demulcent, etc. Products include multi-sphere products, blister lyophilized spheres, syringes lyophilized spheres and lyophilized, and can be applied in cosmetics, nutraceuticals and medical devices fields. Besides, the company also engages in functional skin care products OEM and ODM business. It has many clients, such as Kristina, Huaxi Bio and Davis & Garret. The company generates revenue by developing and providing collagen technology and products.
Who invested in Jiangsu JLand Biotech Co.
5 investors across 3 rounds
See all investors in Jiangsu JLand Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiangsu JLand Biotech Co.
Who invested in Jiangsu JLand Biotech Co.?
Jiangsu JLand Biotech Co. has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiangsu JLand Biotech Co. raised?
Jiangsu JLand Biotech Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiangsu JLand Biotech Co. last raise money?
Jiangsu JLand Biotech Co.'s most recent round on record is a Series C, in May 2025.
What does Jiangsu JLand Biotech Co. do?
Jiangsu JLand Biotech Co. is a biotechnology company.
Where is Jiangsu JLand Biotech Co. headquartered?
Jiangsu JLand Biotech Co. is headquartered in Jingjiang, China.
Which VCs invest in companies like Jiangsu JLand Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jiangsu JLand Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Jiangsu JLand Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.